Dapicost 5 Tablet
Marketer
West-Coast Pharmaceutical Works Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dapicost 5 Tablet
Glyburide 5 mg tablets are indicated, either singularly or in conjunction with other medications, for the management of type 2 diabetes mellitus. Their function is to regulate elevated blood glucose characteristic of this condition, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Glyburide 5 mg tablets may be administered with or without food, at any point during the day, but consistent daily timing is recommended. Dosage should be determined by your physician, and discontinuation should only occur under their supervision, as cessation can lead to elevated blood glucose and increased risk of severe complications such as nephropathy and retinopathy. This medication forms one component of a comprehensive treatment strategy which incorporates a balanced diet, regular physical activity, and weight management, as directed by your doctor. Commonly reported adverse events include vaginal candidiasis, nasopharyngitis, and urinary tract infections. The medication may induce diuresis; therefore, ample fluid intake is essential to prevent dehydration. Practicing good hygiene can help prevent genital fungal infections. Prior to commencing treatment, disclose any pre-existing renal or hepatic impairment, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating women should consult their physician before initiating therapy. Limit alcohol consumption during treatment, as this may enhance the likelihood of adverse effects. Regular blood glucose monitoring is crucial during treatment.
Uses of Dapicost 5 Tablet
Managing Type 2 Diabetes
Major Benefits of Dapicost 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapicost 5 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Dapicost 5 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapicost 5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapicost 5 Tablet can be administered with or without food, though consistent timing is recommended.
How Dapicost 5 Tablet works:
Dapicost 5 tablets manage blood sugar levels. This antidiabetic drug achieves this by promoting urinary excretion of excess glucose.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Dapicost 5 Tablet.
PregnancyCONSULT YOUR DOCTOR
The use of Dapicost 5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Dapicost 5 Tablet use are likely incompatible. Available data in humans indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dapicost 5 Tablet is potentially hazardous for individuals with kidney impairment and is best avoided. Seek medical advice before taking this medication.
LiverSAFE IF PRESCRIBED
Individuals with hepatic impairment can safely use Dapicost 5 Tablet without requiring any modification to the prescribed dosage.
What if you forget to take Dapicost 5 Tablet :
Should you forget to take a Dapicost 5 Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapicost 5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |





